| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |